Wire Stories

Graphene & Solar Technologies New Shareholder Letter & Update

NEWPORT BEACH, Calif.--(BUSINESS WIRE)--(OTC: GSTX) Graphene & Solar Technologies Limited, releases Shareholder Letter & Company…

Graphene & Solar Technologies New Shareholder Letter & Update

NEWPORT BEACH, Calif.--(BUSINESS WIRE)--(OTC: GSTX) Graphene & Solar Technologies Limited, releases Shareholder Letter & Company…

Boston Metal Wins S&P Global Platts Global Metals Award

Winners announced in London, UK BOSTON--(BUSINESS WIRE)--Boston Metal won the New Technology for the Metals…

Graphene & Solar Technologies New Shareholder Letter & Update

NEWPORT BEACH, Calif.--(BUSINESS WIRE)--(OTC: GSTX) Graphene & Solar Technologies Limited, releases Shareholder Letter & Company…

Otsuka Medical Devices’ REQUIRE Trial Results Presented at Japan Society of Hypertension Annual Meeting

REQUIRE trial results published in Hypertension Research journal and simultaneously presented at Japanese Society of…

Otsuka Medical Devices’ REQUIRE Trial Results Presented at Japan Society of Hypertension Annual Meeting

REQUIRE trial results published in Hypertension Research journal and simultaneously presented at Japanese Society of…

Treadwell Therapeutics Announces Acquisition of TCRyption Inc., a Novel TCR-Based T Cell Therapy Company and TIO Bioventures Portfolio Company

Combination brings an additional therapeutic modality into Treadwell’s growing pre-clinical pipeline of first in class…

Otsuka Medical Devices’ REQUIRE Trial Results Presented at Japan Society of Hypertension Annual Meeting

REQUIRE trial results published in Hypertension Research journal and simultaneously presented at Japanese Society of…

Treadwell Therapeutics Announces Acquisition of TCRyption Inc., a Novel TCR-Based T Cell Therapy Company and TIO Bioventures Portfolio Company

Combination brings an additional therapeutic modality into Treadwell’s growing pre-clinical pipeline of first in class…

Treadwell Therapeutics Announces Acquisition of TCRyption Inc., a Novel TCR-Based T Cell Therapy Company and TIO Bioventures Portfolio Company

Combination brings an additional therapeutic modality into Treadwell’s growing pre-clinical pipeline of first in class…